# A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)

> **NCT01661387** · — · TERMINATED · sponsor: **Shire** · enrollment: 3258 (actual)

## Conditions studied

- Chronic Adrenal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01661387
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08-07
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 3258 (ACTUAL)
- **Why stopped:** Takeda submitted 900 patient years Interim Analysis to PRAC and requested study to be closed since primary objective had been fulfilled. PRAC agreed and on 17Sep2020 approved closure of EU-AIR Registry. Takeda announced study closure on 31Oct2020.
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661387, "A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01661387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*